Abstract
Although there have been many developments related to specific strategies for treating patients after poisoning exposures, the mainstay of therapy remains symptomatic and supportive care. One of the most aggressive supportive modalities is extracorporeal membrane oxygenation (ECMO). Our goal was to describe the use of ECMO for toxicological exposures reported to the American College of Medical Toxicology (ACMT) Toxicology Investigators Consortium (ToxIC). We performed a retrospective review of the ACMT ToxIC Registry from January 1, 2010 to December 31, 2013. Inclusion criteria included patients aged 0 to 89 years, evaluated between January 2010 through December 2013, and received ECMO for toxicological exposure. There were 26,271 exposures (60 % female) reported to the ToxIC Registry, 10 (0.0004 %) received ECMO: 4 pediatric (< 12 years), 2 adolescent (12–18 years), and 4 adults (>18 years). Time of initiation of ECMO ranged from 4 h to 4 days, with duration from 15 h to 12 days. Exposures included carbon monoxide/smoke inhalation (2), bitter almonds, methanol, and several medications including antihistamines (2), antipsychotic/antidepressant (2), cardiovascular drugs (2), analgesics (2), sedative/hypnotics (2), and antidiabetics (2). Four ECMO patients received cardiopulmonary resuscitation (CPR) during their hospital course, and the overall survival rate was 80 %. ECMO was rarely used for poisoning exposures in the ACMT ToxIC Registry. ECMO was utilized for a variety of ages and for pharmaceutical and non-pharmaceutical exposures. In most cases, ECMO was administered prior to cardiovascular failure, and survival rate was high. If available, ECMO may be a valid treatment modality.
Similar content being viewed by others
References
Bronstein AC, Spyker DA, Cantelena LR, et al. 2011 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 29th annual report. Clin Toxicol (Phila). 2012;50:911–1164.
Simone KE. Thirty US poison center reports later: greater demand, more difficult problems. Clin Toxicol (Phila). 2014;52(2):91–2.
Centers for Disease Control and Prevention. Web-based Injury Statistics Query and Reporting System (WISQARS) [online]. (2014) http://www.cdc.gov/injury/wisqars/fatal.html. Last Accessed 11/17/2014.
Zobrocki LA, Brogan TV, Statler KD, et al. Extracorporeal membrane oxygenation for pediatric respiratory failure: survival and predictors of mortality. Crit Care Med. 2011;39(2):364–70.
Brodie D, Bacchetta M. Extracorporeal membrane oxygenation for ARDS in adults. N Engl J Med. 2011;365(20):1905–14.
Gattinonni L, Carlesso E, Langer T. Clinical review: extracorporeal membrane oxygenation. Crit Care. 2011;15(6):243.
Ouweneel DM, Henriques JP. Percutaneous cardiac support devices for cardiogenic shock: current indications and recommendations. Heart. 2012;98(16):1246–54.
Lazzeri C, Bernardo P, Sori A, et al. Venous-arterial extracorporeal membrane oxygenation for refractory cardiac arrest: a clinical challenge. Eur Heart J Acute Cardiovasc Care. 2013;2(2):118–26.
Rehder KJ, Turner DA, Cheifetz IM. Extracorporeal membrane oxygenation for neonatal and pediatric respiratory failure: an evidence-based review of the past decade (2002–2012). Pediatr Crit Care Med. 2013;14(9):851–61.
Zampieri FB, Mendes PV, Ranzani OT, et al. Extracorporeal membrane oxygenation for severe respiratory failure in adult patients: a systematic review and meta-analysis of current evidence. J Crit Care. 2013;28(6):998–1005.
Terragni P, Faggiano C, Ranieri VM. Extracorporeal membrane oxygenation in adult patients with acute respiratory distress syndrome. Curr Opin Crit Care. 2014;20(1):86–91.
De Lange DW, Sikma MA, Meulenbelt J. Extracorporeal membrane oxygenation in the treatment of poisoned patients. Clin Toxicol (Phila). 2013;51(5):385–93.
Freedmen MD, Gal J, Freed CR. Extracorporeal pump assistance—novel treatment for acute lidocaine poisoning. Eur J Clin Pharmcol. 1982;22(2):129–35.
Larkin GL, Gaeber GM, Hollingsed MJ. Experimental amitriptyline poisoning: treatment of severe cardiovascular toxicity with cardiopulmonary bypass. Ann Emerg Med. 1994;23(3):480–6.
Hendren WG, Schieber RS, Garrettson LK. Extracorporeal bypass for the treatment of verapamil poisoning. Ann Emerg Med. 1989;18(9):984–7.
Goodwin DA, Lally KP, Null Jr DM. Extracorporeal membrane oxygenation support for cardiac dysfunction from tricyclic antidepressant overdose. Crit Care Med. 1993;21(4):625–7.
Williams JM, Hollingshed MJ, Vasilakis A, et al. Extracorporeal circulation in the management of severe tricyclic antidepressant overdose. Am J Emerg Med. 1994;12(4):456–8.
Rooney M, Massey KL, Jamali F, et al. Acebutolol overdose treated with hemodialysis and extracorporeal membrane oxygenation. J Clin Pharmacol. 1996;36(8):760–3.
Yasui RK, Culclasure TF, Kaufman D, et al. Flecainide overdose: is cardiopulmonary support the treatment? Ann Emerg Med. 1997;29(5):680–2.
Behringer W, Sterz F, Domanovits H, et al. Percutaneous cardiopulmonary bypass for therapy resistant cardiac arrest from digoxin overdose. Resuscitation. 1998;37(1):47–50.
Yoshida K, Kimura K, Hibi K, et al. A patient with disopyramide intoxication rescued by percutaneous cardiopulmonary support. J Cardiol. 1998;32(2):95–100.
Corkeron MA, van Heerden PV, Newman SM, et al. Extracorporeal circulatory support in near-fatal flecainide overdose. Anaesth Intensive Care. 1999;27(4):405–8.
Holzer M, Sterz F, Schoerkhuber W, et al. Successful resuscitation of a verapamil-intoxicated patient with percutaneous cardiopulmonary bypass. Crit Care Med. 1999;27(12):2818–23.
Durward A, Guerguerian AM, Lefebvre M, et al. Massive diltiazem overdose treated with extracorporeal membrane oxygenation. Pediatr Crit Care Med. 2003;4(3):372–6.
Vivien B, Deye N, Megarbane B, et al. Extracorporeal life support in a case of fatal flecainide and betaxolol poisoning allowing successful cardiac allograft. Ann Emerg Med. 2010;56(4):409–12.
Shenoi AN, Gertz SJ, Mikkilineni S, et al. Refractory hypotension from massive bupropion overdose successfully treated with extracorporeal membrane oxygenation. Pediatr Emerg Care. 2011;27(1):43–5.
Johnson NH, Gaieski DF, Allen SR, et al. A review of emergency cardiopulmonary bypass for severe poisoning by cardiotoxic drugs. J Med Toxicol. 2013;99(1):54–60.
Daubin C, Lehoux P, Ivascau C, et al. Extracorporeal life support in severe drug intoxication: a retrospective cohort study of seventeen cases. Crit Care. 2009;13(4):R138.
Masson R, Colas V, Parienti JJ, et al. A comparison of survival with and without extracorporeal life support treatment for severe poisoning due to drug intoxication. Resuscitation. 2012;83(11):1413–7.
Chyka PA. Benefits of extracorporeal membrane oxygenation for hydrocarbon pneumonitis. J Toxicol Clin Toxicol. 1996;34(4):357–63.
Bur A, Wagner A, Roggla M, et al. Fatal pulmonary edema after nitric acid inhalation. Resuscitation. 1997;35(1):33–6.
McCunn M, Reynolds HN, Cottingham CA, et al. Extracorporeal support in an adult with severe carbon monoxide poisoning and shock following smoke inhalation: a case report. Perfusion. 2000;15(2):169–73.
Lai MW, Boywer EW, Llein ME, et al. Acute arsenic poisoning in two siblings. Pediatrics. 2005;116(1):249–57.
Chian CF, Wu CP, Chen CW, et al. Acute respiratory distress syndrome after zinc chloride inhalation: survival after extracorporeal life support and corticosteroid treatment. Am J Crit Care. 2010;19(1):86–90.
Panzeri C, Bacis G, Ferri F, et al. Extracorporeal life support in a severe Taxus baccata poisoning. Clin Toxicol (Phila). 2010;48(5):463–5.
Rhyee SH, Farrugia L, Wiegand T, et al. The toxicology investigators consortium case registry—the 2013 experience. J Med Toxicol. 2014;10(4):342–59.
Wiegand T, Wax P, Smith E, et al. The toxicology investigators consortium case registry—the 2012 experience. J Med Toxicol. 2013;9(4):380–404.
Wiegand TJ, Wax PM, Schwartz T, et al. The toxicology investigators consortium case registry—the 2011 experience. J Med Toxicol. 2012;8(4):360–77.
Brent J, Wax PM, Schwartz T, et al. The toxicology investigators consortium case registry—the 2010 experience. J Med Toxicol. 2011;7(4):266–76.
Christenson J, Andrusiek D, Everson-Stewart S, et al. Chest compression fracture determines survival in patients with out-of-hospital ventricular fibrillation. Circulation. 2009;120(13):1241–7.
Vaillancourt C, Everson-Stewart S, Christenson J, et al. The impact of increased chest compression fracture on return of spontaneous circulation for out-of-hospital cardiac arrest patients not in ventricular fibrillation. Resuscitation. 2011;82(1):1501–7.
Cheng R, Hachamovitch R, Kittleson M, et al. Complications of extracorporeal membrane oxygenation for treatment of cardiogenic shock and cardiac arrest: a meta-analysis of 1,866 adult patients. Ann Thorac Surg. 2014;97(2):610–6.
Zangrillo A, Landoni G, Biondi-Zoccai G, et al. A meta-analysis of complications and mortality of extracorporeal membrane oxygenation. Crit Care Resusc. 2013;15(3):172–8.
Sources of Funding
None
Conflicts of Interest
The authors declare that they have no competing interests.
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, G.S., Levitan, R., Wiegand, T.J. et al. Extracorporeal Membrane Oxygenation (ECMO) for Severe Toxicological Exposures: Review of the Toxicology Investigators Consortium (ToxIC). J. Med. Toxicol. 12, 95–99 (2016). https://doi.org/10.1007/s13181-015-0486-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13181-015-0486-8